CoreWeave, Inc. SEC Filings

CoreWeave insider sales under a Rule 10b5-1 plan: SVP of Engineering Goldberg Chen sold a total of 56,294 shares of Class A common stock in multiple transactions executed on 09/02/2025, using a pre-established 10b5-1 trading plan. Sales occurred across several price bands with weighted-average prices reported between about $90.76 and $96.77 per share. After these dispositions the reporting person’s remaining direct beneficial ownership is reported as 18,764 shares. The Form 4 discloses the transactions, the 10b5-1 plan adoption date, and weighted-average price ranges for each tranche of shares sold.

CoreWeave insider sale via 10b5-1 plan: Director Jack D. Cogen reported multiple sales of Class A common stock on 09/02/2025 executed under a Rule 10b5-1 trading plan adopted May 22, 2025. The Form 4 lists individual dispositions of 90,888; 160,174; 250,665; 473,236; 136,113; 928; and 261,140 shares at weighted-average prices ranging from $91.84 to $96.90 per share, resulting in large reductions in shares held indirectly through CW Holding 987 LLC. The filing discloses extensive remaining indirect holdings and trust/entity allocations, including a reported 1,200,000 shares held in the Cherry Tree 2024 GRAT and multiple family trust and LLC holdings. The Form 4 was signed by an attorney-in-fact on 09/04/2025.

CoreWeave, Inc. (CRWV) Form 144 shows a proposed sale of 281,250 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $26,251,875.00. The shares were acquired as Founders Shares on 12/27/2023. The filing lists multiple recent 10b5-1 sales during Aug–Sep 2025, including a 281,250-share sale by WEST CLAY CAPITAL LLC on 08/20/2025 for $24,777,421.88 and smaller 10b5-1 transactions on 09/02/2025. The filer represents no undisclosed material adverse information and references reliance on 10b5-1 plans where applicable.

CoreWeave insider Form 4: Multiple Magnetar-related entities reported sales of Class A common stock on 08/29/2025. The filing shows a series of dispositions totaling 80,820 shares across multiple Magnetar funds and vehicles at prices reported between $102.09 and $102.39, with a stated weighted average price footnote. The report lists remaining indirect beneficial holdings by the reporting group across several funds, with individual post-transaction balances shown for each entity. The filing includes detailed disclosure of the reporting chain: Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC and David J. Snyderman, and contains footnotes explaining direct holders and disclaimers of beneficial ownership.

CoreWeave, Inc. (CRWV) Form 144 filing notifies a proposed sale of 1,112,004 shares of common stock through Goldman Sachs & Co. LLC with an aggregate market value of $103,794,453.36, and lists 370,470,348 shares outstanding. The filing states the shares were acquired as founder shares from the issuer on 02/25/2019 and that payment was None at acquisition. It also discloses multiple recent sales by related trusts on 08/14/2025 and 08/15/2025, including a sale of 2,556,000 shares for $231,445,800. The filer represents they are not aware of any undisclosed material adverse information.

CoreWeave, Inc. (CRWV) filing reports a proposed sale of 56,294 common shares, acquired as restricted stock units on 08/05/2025. The broker listed is Morgan Stanley Smith Barney LLC and the sale is scheduled approximately for 09/02/2025 on NASDAQ. The filing shows an aggregate market value of $5,800,533.76 based on the proposed sale and reports 370,470,348 shares outstanding. No securities were sold by the reporting person in the past three months. The filer certifies they are unaware of undisclosed material adverse information and references Rule 10b5-1 procedures if applicable.

CoreWeave, Inc. (CRWV) Form 144 notice reports a planned sale of 375,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $38,640,000, and lists 370,470,348 shares outstanding. The shares to be sold were acquired as founders' shares on 11/13/2017. The filing also discloses recent Rule 10b5-1 executed sales by related parties: two sales of 375,000 and two sales of 250,000 common shares on 08/19/2025 and 08/26/2025, generating gross proceeds shown for each transaction. The filer affirms they are not aware of undisclosed material adverse information in the issuer.

Form 144 filed for CoreWeave, Inc. (CRWV) reporting a proposed sale of 250,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $25,760,000. The shares were originally acquired as founders' shares on 11/13/2017. The filing shows prior Rule 10b5-1 sales in August 2025 that sold a total of 1,250,000 shares for gross proceeds of $114,808,500. The company has 370,470,348 shares outstanding, and the planned sale is scheduled for 09/02/2025 on NASDAQ. The filer certifies no undisclosed material adverse information and references reliance on Rule 10b5-1 trading arrangements for recent sales.

CoreWeave, Inc. (CRWV) Form 144 notice reports a proposed sale of 19,410 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $2,000,006.40, scheduled approximately for 09/02/2025 on NASDAQ. The shares were acquired as Founders Shares from the issuer on 12/27/2023. The filing also discloses 10b5-1 plan sales in the prior three months: 281,250 shares by WEST CLAY CAPITAL LLC for $24,777,421.88 and two trust sales of 21,531 shares each for $1,896,827.27 each, all dated 08/20/2025. Total shares outstanding reported in the form are 370,470,348. The filer certifies no undisclosed material adverse information and references reliance on Rule 10b5-1 where applicable.